Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus.

Arthur E FrankelWai C YipEknath NaikHans Carl Carl Hasselbalch

Published in: Clinical case reports (2021)

A 61-year-old male on everolimus had chronic SARS-CoV-2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID-19.

Keyphrases

sars cov
combination therapy
coronavirus disease
dendritic cells
respiratory syndrome coronavirus
squamous cell carcinoma
small cell lung cancer
recombinant human
newly diagnosed